MECOCCI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 9.987
EU - Europa 9.401
AS - Asia 2.930
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 17
AF - Africa 5
OC - Oceania 5
Totale 22.373
Nazione #
US - Stati Uniti d'America 9.942
IT - Italia 2.759
IE - Irlanda 1.805
UA - Ucraina 1.526
SE - Svezia 1.215
SG - Singapore 815
HK - Hong Kong 756
VN - Vietnam 723
FI - Finlandia 427
RU - Federazione Russa 385
DE - Germania 352
FR - Francia 326
CN - Cina 319
GB - Regno Unito 183
KR - Corea 113
CH - Svizzera 104
AT - Austria 99
TR - Turchia 81
PL - Polonia 48
BE - Belgio 35
CA - Canada 32
NL - Olanda 32
CZ - Repubblica Ceca 30
UZ - Uzbekistan 29
GR - Grecia 23
IR - Iran 23
MY - Malesia 20
RO - Romania 20
EU - Europa 17
BR - Brasile 16
LB - Libano 16
IN - India 15
MX - Messico 11
BG - Bulgaria 8
PH - Filippine 8
ES - Italia 7
JP - Giappone 5
CO - Colombia 4
SK - Slovacchia (Repubblica Slovacca) 4
AU - Australia 3
CL - Cile 3
DK - Danimarca 3
EC - Ecuador 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
IQ - Iraq 2
NZ - Nuova Zelanda 2
PE - Perù 2
AL - Albania 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
JM - Giamaica 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
SA - Arabia Saudita 1
SV - El Salvador 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 22.373
Città #
Chandler 1.972
Dublin 1.803
San Mateo 897
Jacksonville 836
Boardman 781
Hong Kong 755
Dong Ket 722
Singapore 530
Altamura 525
Medford 468
Princeton 464
Lawrence 398
Wilmington 344
Perugia 303
Andover 268
Ann Arbor 230
Beijing 168
Des Moines 132
Rome 121
Saint Petersburg 121
Norwalk 101
Seoul 100
Redmond 94
Milan 92
Falls Church 83
Izmir 74
Helsinki 73
San Paolo di Civitate 70
Los Angeles 65
Ashburn 64
Vienna 63
Woodbridge 60
Houston 53
Redwood City 46
New York 43
Santa Clara 43
Dallas 38
Dearborn 34
Munich 34
Palermo 34
Lappeenranta 32
Brussels 31
Florence 29
Terni 29
Bologna 28
Moscow 26
Naples 26
Auburn Hills 25
Kraków 25
Prato 25
Padova 24
Ardabil 22
Monmouth Junction 21
Bari 20
Shanghai 20
Toronto 20
Den Haag 19
Brno 17
Chicago 17
Frankfurt Am Main 16
Caserta 14
Civitavecchia 14
Brescia 13
Torino 13
Turin 13
Verona 13
Napoli 11
Assisi 9
Cornigliano 9
Lausanne 9
Lugano 9
Venezia 9
Bergamo 8
Catania 8
Fairfield 8
Paris 8
San Diego 8
Pescara 7
Seattle 7
Sesto Fiorentino 7
Tappahannock 7
Udine 7
Collazzone 6
Genoa 6
Pisa 6
Tyresö 6
Vernio 6
Castelnuovo Rangone 5
Chiaravalle 5
Concesio 5
Kuala Lumpur 5
Livorno 5
Nanning 5
Olomouc 5
Parma 5
Philadelphia 5
Ravenna 5
Rovereto 5
Treviso 5
Vicenza 5
Totale 13.880
Nome #
Validazione della versione italiana della Geriatric Depression Scale a 5 item in tre differenti setting assistenziali 1.362
I disturbi comportamentali “clinicamente rilevanti” nella demenza vascolare, nella demenza a corpi di Lewy e nella demenza di Alzheimer: studio su 921 pazienti anziani. 264
Musicalmente: sviluppo di un paradigma per la valutazione dell’efficacia della musicoterapia nel trattamento della demenza 155
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 112
The brain of the elderly between normality and pathology: Techniques and technologies for the evaluation 106
Antiossidanti plasmatici e longevità: studio su centenari sani 106
Validation study of the Italian Addenbrooke’s Cognitive Examination Revised in a young-old and old-old population 106
Fracture prevention service to bridge the osteoporosis care gap 104
Antioxidants for the treatment of mild cognitive impairment. (Review) 103
Platelet MAO-B activity and vitamin B12 in old age dementias. 102
Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics. 102
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 98
Oxidative stress and dementia: new perspectives in AD pathogenesis. 96
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. 92
The orthogeriatric management: an inseparable duo to foster appropriate care 92
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 91
Alterazioni biochimiche nel cervello di soggetti con ipertensione cronica e in pazienti con demenza di Alzheimer in fase precoce valutate mediante risonanza magnetica spettroscopica 89
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 87
Axonal injury within language network in primary progressive aphasia 86
Dementia, depression and parkinsonism: A frequent association in the elderly. 85
Heart disease and vascular risk factors in the cognitively impaired elderly: implications for Alzheimer's dementia 85
Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts 84
La risonanza magnetica spettroscopica differenzia il Mild Cognitive Impairment dal normale invecchiamento cerebrale 82
Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease. 82
Hippocampal atrophy in people with memory deficits: results from the population-based IPREA study 81
Predicting progression of Alzheimer's disease using ordinal regression 81
Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer’s disease 81
Attività dell'Aconitasi Mitocondriale nella demenza di Alzheimer e nel Mild cognitive impairment 81
The effects of aging and endurance exercise on cardiovascular performance in healthy elderly: a review of the literature. 81
Approccio diagnostico ai disturbi cognitivi in corso di patologie somatiche nell’anziano. 80
Vitamin D supplementation with calcidiol and cholecalciferol among oldest-old persons 80
Pharmaceutical treatment of cognitive disorders in Alzheimer's disease. 79
Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation 79
Insight, cognition and quality of life in Alzheimer's disease. 79
Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity 79
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 78
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 78
An ontology-based personalization of health-care knowledge to support clinical decisions for chronically ill patients 78
Association of increased carotid intima-media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer's disease 77
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. 77
Common genetic variants influence human subcortical brain structures. 76
Antioxidants micronutrients in the prevention of age-related diseases: focus on Alzheimer’s disease 76
Cognitive Impairment Is the Major Risk Factor for Development of Geriatric Syndromes during Hospitalization: Results from the GIFA Study 76
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a mendelian randomization analysis. 75
Generalizability of the Disease State Index Prediction Model for Identifying Patients Progressing from Mild Cognitive Impairment to Alzheimer's Disease. 75
Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status : Results from the Zincage Project. 75
Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. 74
Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. 74
Normative data for the ACE-R in an Italian population sample. 74
Metabolic syndrome and risk of dementia in older adults. 73
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 72
Circulating Proteomic Signatures of Chronological Age 72
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 72
Deterioramento cognitivo e sviluppo di sindromi geriatriche durante il ricovero ospedaliero: risultati dello studio GIFA 72
The orthogeriatric comanagement improves clinical outcomes of hip fracture in older adults 72
Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort 71
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. 71
Alzheimer's disease: clinical trials and drug development. 71
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 71
Nutraceuticals in cognitive impairment and Alzheimer's disease 71
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey 70
FASTKD2 is associated with memory and hippocampal structure in older adults 70
The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months 70
Blood pressure and functional aspects of the aging brain. 70
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. 70
Gli effetti dell’anemia e dell’emotrasfusione sugli indicatori clinici nel paziente anziano con frattura di femore. 70
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 69
Altered mitochondrial membrane fluidity in AD brain. 69
Paziente anziano, paziente geriatrico e medicina della complessità. Fondamenti di Gerontologia e Geriatria (III edizione) 68
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy. 67
Paziente anziano, Paziente geriatrico 67
Area-specific differences in OH8dG and mtDNA4977 levels in Alzheimer disease patients and aged controls. 67
Topics in clinical pharmacology: cardiovascular and diabetes mellitus. 67
Le demenze vascolari 67
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease 66
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 66
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America 66
Age and sex influence on oxidative damage and functional status in human skeletal muscle. 66
High vitamin E plasma levels and low low-density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians. 65
Antioxidant agents in Alzheimer’s disease 65
Validation of the five-item geriatric depression scale in elderly subjects in three different settings. 65
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment 64
Elevati livelli plasmatici delle forme di vitamina E e riduzione del rischio di malattia di Alzheimer in età avanzata 64
Anticholinergic burden and functional status in older people with cognitive impairment: Results from the ReGAl project 64
Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific Cytokinome Signature 63
AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. 63
Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle 62
Antioxidant profile and early outcome in stroke patients. 62
H-1-MR spectroscopy differentiates mild cognitive impairment from normal brain aging 62
Different antioxidant profiles in Italian centenarians: the Sardinian peculiarity. 61
The Caregiver Burden Inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study 61
Il ruolo dei fattori di rischio vascolare nei sottotipi di mild cognitive impairment. Risultati del progetto ReGAl 61
Influenza della comorbilità e dello stato cognitivo sulle attività strumentali della vita quotidiana nei soggetti con Mild Cognitive Impairment Amnesico (aMCI): risultati del Progetto ReGAl. 61
Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood. 61
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 61
Depression in the elderly: new concepts and therapeutic approaches. 60
Elevated lipid peroxidation biomarkers and low antioxidant status in atherosclerotic patients with increased carotid and iliofemoral intima-media thickness 60
Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder 60
A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks. 60
Lower serum levels of IL-13 is associated with increased carotid intima-media thickness in old age subjects 60
Totale 9.093
Categoria #
all - tutte 102.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.625 0 0 0 35 273 74 265 75 491 159 60 193
2020/20214.153 41 219 181 236 1.067 236 250 31 451 334 316 791
2021/20223.858 158 686 128 245 137 70 71 1.130 121 121 447 544
2022/20236.940 502 1.378 76 528 536 698 89 342 2.437 60 205 89
2023/20242.988 204 331 158 97 29 26 480 130 426 124 506 477
2024/20251.267 186 746 331 4 0 0 0 0 0 0 0 0
Totale 23.693